Medicine and Dentistry
Patient
100%
Transplantation
76%
Hematopoietic Cell
72%
Infection
71%
Cell Transplantation
58%
Therapeutic Procedure
38%
Mortality
30%
Donor
26%
Blood
26%
Diagnosis
21%
Graft Versus Host Reaction
20%
Prophylaxis
18%
Mycosis
18%
Infectious Complication
17%
Cord Blood
17%
Pathogen
16%
Cord Blood Stem Cell Transplantation
15%
Combination Therapy
14%
Immunosuppressive Treatment
14%
Hematopoietic Stem Cell Transplantation
14%
Hematopoietic Stem Cell
13%
Hematologic Malignancy
13%
Stem Cell Transplant
13%
Inpatient
13%
Incidence
12%
Bloodstream Infection
12%
Bacteremia
12%
Steroid
12%
Allotransplantation
12%
Polymerase Chain Reaction
12%
Engraftment
12%
Infectious Disease
11%
Fever
11%
Bacterial Infection
11%
Aspergillosis
11%
Granulocyte Colony Stimulating Factor
11%
Depletion
11%
Disease
10%
Cytomegalovirus
10%
Vaccine
10%
Organ
10%
Neutropenia
10%
Pediatrics
10%
Survival
9%
Granulocyte
9%
Thymocyte Antibody
9%
Analysis
9%
Complication
9%
T Cell
9%
Cytomegalovirus Infection
9%
Immunology and Microbiology
Transplantation
92%
Cell Transplantation
54%
Cytomegalovirus
31%
Mortality
28%
Umbilical Cord Blood
23%
Cells
23%
Incidence
20%
Cord Blood Stem Cell Transplantation
19%
Hematopoietic Stem Cell Transplantation
17%
Cytomegalovirus Infection
16%
Time
15%
Hematopoietic Stem Cell Transplantation
14%
Conditioning
14%
Engraftment
14%
Organ
13%
Solid
12%
Dose
12%
Candida Albicans
12%
Aspergillus
11%
Graft-Versus-Host Disease
11%
Granulocyte Colony-Stimulating Factor
11%
Bone Marrow
11%
Infectious Agent
10%
Survival
10%
Vaccine Efficacy
9%
Neutrophil Granulocyte
8%
Vancomycin-Resistant Enterococcus
8%
Anti-Thymocyte Globulin
8%
Viral Disease
7%
Overall Survival
7%
T Cell Depletion
7%
Epstein Barr Virus
7%
Clostridium difficile
7%
Development
7%
Viremia
5%
Immune Reconstitution
5%
CD19
5%
Allotransplantation
5%
Lymphoproliferative Disorders
5%
Stem Cell
5%
T Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
34%
Blindness
19%
Neutropenia
17%
Mycosis
16%
Micafungin
16%
Fluconazole
15%
Invasive Aspergillosis
15%
Diseases
13%
Fever
13%
Cytomegalovirus Infection
12%
Mortality
11%
Clinical Trial
10%
Incidence
10%
Cytomegalovirus
9%
Malignant Neoplasm
9%
Antifungal Therapy
8%
Bacteremia
8%
Hematologic Malignancy
8%
Bloodstream Infection
8%
Amphotericin B
7%
Zygomycosis
7%
Varicella Zoster Vaccine
7%
Benzimidavir
7%
Placebo
7%
Graft Versus Host Reaction
6%
Infectious Agent
6%
Recurrent Disease
6%
Systemic Mycosis
5%
Antibiotic Therapy
5%
Immunocompromised Patient
5%
Antifungal
5%
Aciclovir
5%